Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements
Screening tools such as calf circumference (CC) and Yubi-wakka (finger-ring) test have been recognized as effective tools by Asian Working Group for Sarcopenia 2019 (AWGS'19) for sarcopenia screening but their comparative agreement, diagnostic performance and validity are unclear. This study ai...
Gespeichert in:
| Veröffentlicht in: | Journal of Frailty & Aging 2024, Vol.13 (2), p.98-107 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107 |
|---|---|
| container_issue | 2 |
| container_start_page | 98 |
| container_title | Journal of Frailty & Aging |
| container_volume | 13 |
| creator | Piodena-Aportadera, M R B Lau, S Tan, C N Chew, J Lim, J P Ismail, N H Ding, Y Y Lim, W S |
| description | Screening tools such as calf circumference (CC) and Yubi-wakka (finger-ring) test have been recognized as effective tools by Asian Working Group for Sarcopenia 2019 (AWGS'19) for sarcopenia screening but their comparative agreement, diagnostic performance and validity are unclear.
This study aims to determine: (i)agreement between calf and finger-ring circumference, (ii)diagnostic performance for low muscle mass and AWGS'19 sarcopenia diagnosis, (iii)correlation with muscle mass, strength, and physical performance, and (iv)association with frailty, life space mobility and physical activity.
We studied 187 healthy community-dwelling older adults (mean age=66.8+7.0years) from the GERILABS-2 study. CC was measured via (i) both calves in sitting and standing positions, and (ii) Yubi-wakka test by encircling the thickest part of the non-dominant calf with index fingers and thumbs of both hands. We performed Cohen's kappa to check for agreement, area under receiver operating characteristic curve (AUC) to compare diagnostic performance, partial correlations adjusted for age and gender to compare convergent validity, and logistic regression to determine predictive validity for outcome measures.
Sarcopenia prevalence was 24.0% (AWGS'19). Yubi-wakka identified 16.6% of participants as screen-positive ("smaller"), showing moderate agreement only with non-dominant sitting CC measurements (k=0.421,p |
| doi_str_mv | 10.14283/jfa.2024.25 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3039234979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3037706994</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-433d6d15c8ada0d30cea56041b71f3b85de252b08efbea2f384c9c04b0cec3f93</originalsourceid><addsrcrecordid>eNpd0c1u1TAQBWALgWhVumONLLFh0Vxsj_PHrgoUkIpAagGxiibO-Na3iXOxE6q-Ck-L0xYWrDyLz0f2HMaeS7GRWlXwemdxo4TSG5U_YodKlZBpEPXjdS5EJkHLA3Yc404IoaQWpa6esgOoCllAkR-y3z-WzmXf8foa-SXFmdsp8AsMZtqTd8gvTKA0-C13ns9XxJtpHBfv5ts367jHgLP7Rfx0m9xIfj7hbx1u_RRnZ_gXCilvRG-Io-_5Nxxcn-7yGzdf8QYHyxsXzDJaCrSiT4RxCXdB8Rl7YnGIdPxwHrGvZ-8umw_Z-ef3H5vT88yA1HP6LvRFL3NTYY-iB2EI80Jo2ZXSQlflPalcdaIi2xEqC5U2tRG6S9CAreGIvbrP3Yfp55J20I4uGhoG9DQtsQUBtQJdlyt9-R_dTUvw6XWrKktR1LVO6uRemTDFGMi2--BGDLetFO1dbW2qrV1ra1We-IuH0KUbqf-H_5YEfwCJspUx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037706994</pqid></control><display><type>article</type><title>Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements</title><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Springer Nature - Complete Springer Journals</source><source>ProQuest Central Korea</source><source>ProQuest Central UK/Ireland</source><source>ProQuest Central</source><creator>Piodena-Aportadera, M R B ; Lau, S ; Tan, C N ; Chew, J ; Lim, J P ; Ismail, N H ; Ding, Y Y ; Lim, W S</creator><creatorcontrib>Piodena-Aportadera, M R B ; Lau, S ; Tan, C N ; Chew, J ; Lim, J P ; Ismail, N H ; Ding, Y Y ; Lim, W S</creatorcontrib><description>Screening tools such as calf circumference (CC) and Yubi-wakka (finger-ring) test have been recognized as effective tools by Asian Working Group for Sarcopenia 2019 (AWGS'19) for sarcopenia screening but their comparative agreement, diagnostic performance and validity are unclear.
This study aims to determine: (i)agreement between calf and finger-ring circumference, (ii)diagnostic performance for low muscle mass and AWGS'19 sarcopenia diagnosis, (iii)correlation with muscle mass, strength, and physical performance, and (iv)association with frailty, life space mobility and physical activity.
We studied 187 healthy community-dwelling older adults (mean age=66.8+7.0years) from the GERILABS-2 study. CC was measured via (i) both calves in sitting and standing positions, and (ii) Yubi-wakka test by encircling the thickest part of the non-dominant calf with index fingers and thumbs of both hands. We performed Cohen's kappa to check for agreement, area under receiver operating characteristic curve (AUC) to compare diagnostic performance, partial correlations adjusted for age and gender to compare convergent validity, and logistic regression to determine predictive validity for outcome measures.
Sarcopenia prevalence was 24.0% (AWGS'19). Yubi-wakka identified 16.6% of participants as screen-positive ("smaller"), showing moderate agreement only with non-dominant sitting CC measurements (k=0.421,p<0.001) and having lower diagnostic performance in determining low muscle mass (AUC=0.591 vs 0.855-0.870,p<0.001; sensitivity=57.1% vs 75.5-90.8%; specificity=58.4% vs 70.8-80.9%) and sarcopenia diagnosis (AUC=0.581 vs 0.788-0.818,p<0.001; sensitivity=55.6% vs 57.5-71.8%; specificity=74.4% vs 75.6-88.9%) compared to CC measurements. Yubi-wakka correlated significantly with muscle mass, grip strength and knee extension but not physical performance. When adjusted for age, gender and hypertension, Yubi-wakka was significantly associated with frailty (OR=3.96,95%CI:1.09-14.38), life space mobility (OR=2.38,95%CI:1.08-5.24) and physical activity (OR=2.50,95%CI:1.07-5.86).
Yubi-wakka provides a self-administered, low-cost and practicable community screening tool for sarcopenia. Our study affirmed the convergent and predictive validity of Yubi-wakka, albeit with lower sensitivity and specificity in diagnostic performance compared to CC measurements.</description><identifier>ISSN: 2260-1341</identifier><identifier>ISSN: 2273-4309</identifier><identifier>EISSN: 2273-4309</identifier><identifier>DOI: 10.14283/jfa.2024.25</identifier><identifier>PMID: 38616365</identifier><language>eng</language><publisher>France: Springer Nature B.V</publisher><subject>Aged ; Agreements ; Atrophy ; Body mass index ; Clinical medicine ; Community ; Convergent validity ; Cross-sectional studies ; Exercise ; Fingers ; Frailty ; Gender ; Grip strength ; Hand Strength ; Health care ; Hemoglobin ; Humans ; Hypertension ; Knee Joint ; Liver cancer ; Medical diagnosis ; Medical screening ; Metabolic syndrome ; Middle age ; Mobility ; Mortality ; Musculoskeletal system ; Older people ; Physical activity ; Predictive validity ; Primary care ; Risk factors ; Sarcopenia ; Sarcopenia - diagnosis ; Sarcopenia - epidemiology ; Tests ; Thumbs ; Validity ; Working groups</subject><ispartof>Journal of Frailty & Aging, 2024, Vol.13 (2), p.98-107</ispartof><rights>Serdi 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908,30982,33513,33514,33727,33728,33988,33989,64366,64368</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38616365$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piodena-Aportadera, M R B</creatorcontrib><creatorcontrib>Lau, S</creatorcontrib><creatorcontrib>Tan, C N</creatorcontrib><creatorcontrib>Chew, J</creatorcontrib><creatorcontrib>Lim, J P</creatorcontrib><creatorcontrib>Ismail, N H</creatorcontrib><creatorcontrib>Ding, Y Y</creatorcontrib><creatorcontrib>Lim, W S</creatorcontrib><title>Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements</title><title>Journal of Frailty & Aging</title><addtitle>J Frailty Aging</addtitle><description>Screening tools such as calf circumference (CC) and Yubi-wakka (finger-ring) test have been recognized as effective tools by Asian Working Group for Sarcopenia 2019 (AWGS'19) for sarcopenia screening but their comparative agreement, diagnostic performance and validity are unclear.
This study aims to determine: (i)agreement between calf and finger-ring circumference, (ii)diagnostic performance for low muscle mass and AWGS'19 sarcopenia diagnosis, (iii)correlation with muscle mass, strength, and physical performance, and (iv)association with frailty, life space mobility and physical activity.
We studied 187 healthy community-dwelling older adults (mean age=66.8+7.0years) from the GERILABS-2 study. CC was measured via (i) both calves in sitting and standing positions, and (ii) Yubi-wakka test by encircling the thickest part of the non-dominant calf with index fingers and thumbs of both hands. We performed Cohen's kappa to check for agreement, area under receiver operating characteristic curve (AUC) to compare diagnostic performance, partial correlations adjusted for age and gender to compare convergent validity, and logistic regression to determine predictive validity for outcome measures.
Sarcopenia prevalence was 24.0% (AWGS'19). Yubi-wakka identified 16.6% of participants as screen-positive ("smaller"), showing moderate agreement only with non-dominant sitting CC measurements (k=0.421,p<0.001) and having lower diagnostic performance in determining low muscle mass (AUC=0.591 vs 0.855-0.870,p<0.001; sensitivity=57.1% vs 75.5-90.8%; specificity=58.4% vs 70.8-80.9%) and sarcopenia diagnosis (AUC=0.581 vs 0.788-0.818,p<0.001; sensitivity=55.6% vs 57.5-71.8%; specificity=74.4% vs 75.6-88.9%) compared to CC measurements. Yubi-wakka correlated significantly with muscle mass, grip strength and knee extension but not physical performance. When adjusted for age, gender and hypertension, Yubi-wakka was significantly associated with frailty (OR=3.96,95%CI:1.09-14.38), life space mobility (OR=2.38,95%CI:1.08-5.24) and physical activity (OR=2.50,95%CI:1.07-5.86).
Yubi-wakka provides a self-administered, low-cost and practicable community screening tool for sarcopenia. Our study affirmed the convergent and predictive validity of Yubi-wakka, albeit with lower sensitivity and specificity in diagnostic performance compared to CC measurements.</description><subject>Aged</subject><subject>Agreements</subject><subject>Atrophy</subject><subject>Body mass index</subject><subject>Clinical medicine</subject><subject>Community</subject><subject>Convergent validity</subject><subject>Cross-sectional studies</subject><subject>Exercise</subject><subject>Fingers</subject><subject>Frailty</subject><subject>Gender</subject><subject>Grip strength</subject><subject>Hand Strength</subject><subject>Health care</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Knee Joint</subject><subject>Liver cancer</subject><subject>Medical diagnosis</subject><subject>Medical screening</subject><subject>Metabolic syndrome</subject><subject>Middle age</subject><subject>Mobility</subject><subject>Mortality</subject><subject>Musculoskeletal system</subject><subject>Older people</subject><subject>Physical activity</subject><subject>Predictive validity</subject><subject>Primary care</subject><subject>Risk factors</subject><subject>Sarcopenia</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - epidemiology</subject><subject>Tests</subject><subject>Thumbs</subject><subject>Validity</subject><subject>Working groups</subject><issn>2260-1341</issn><issn>2273-4309</issn><issn>2273-4309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNpd0c1u1TAQBWALgWhVumONLLFh0Vxsj_PHrgoUkIpAagGxiibO-Na3iXOxE6q-Ck-L0xYWrDyLz0f2HMaeS7GRWlXwemdxo4TSG5U_YodKlZBpEPXjdS5EJkHLA3Yc404IoaQWpa6esgOoCllAkR-y3z-WzmXf8foa-SXFmdsp8AsMZtqTd8gvTKA0-C13ns9XxJtpHBfv5ts367jHgLP7Rfx0m9xIfj7hbx1u_RRnZ_gXCilvRG-Io-_5Nxxcn-7yGzdf8QYHyxsXzDJaCrSiT4RxCXdB8Rl7YnGIdPxwHrGvZ-8umw_Z-ef3H5vT88yA1HP6LvRFL3NTYY-iB2EI80Jo2ZXSQlflPalcdaIi2xEqC5U2tRG6S9CAreGIvbrP3Yfp55J20I4uGhoG9DQtsQUBtQJdlyt9-R_dTUvw6XWrKktR1LVO6uRemTDFGMi2--BGDLetFO1dbW2qrV1ra1We-IuH0KUbqf-H_5YEfwCJspUx</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Piodena-Aportadera, M R B</creator><creator>Lau, S</creator><creator>Tan, C N</creator><creator>Chew, J</creator><creator>Lim, J P</creator><creator>Ismail, N H</creator><creator>Ding, Y Y</creator><creator>Lim, W S</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>2024</creationdate><title>Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements</title><author>Piodena-Aportadera, M R B ; Lau, S ; Tan, C N ; Chew, J ; Lim, J P ; Ismail, N H ; Ding, Y Y ; Lim, W S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-433d6d15c8ada0d30cea56041b71f3b85de252b08efbea2f384c9c04b0cec3f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Agreements</topic><topic>Atrophy</topic><topic>Body mass index</topic><topic>Clinical medicine</topic><topic>Community</topic><topic>Convergent validity</topic><topic>Cross-sectional studies</topic><topic>Exercise</topic><topic>Fingers</topic><topic>Frailty</topic><topic>Gender</topic><topic>Grip strength</topic><topic>Hand Strength</topic><topic>Health care</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Knee Joint</topic><topic>Liver cancer</topic><topic>Medical diagnosis</topic><topic>Medical screening</topic><topic>Metabolic syndrome</topic><topic>Middle age</topic><topic>Mobility</topic><topic>Mortality</topic><topic>Musculoskeletal system</topic><topic>Older people</topic><topic>Physical activity</topic><topic>Predictive validity</topic><topic>Primary care</topic><topic>Risk factors</topic><topic>Sarcopenia</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - epidemiology</topic><topic>Tests</topic><topic>Thumbs</topic><topic>Validity</topic><topic>Working groups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piodena-Aportadera, M R B</creatorcontrib><creatorcontrib>Lau, S</creatorcontrib><creatorcontrib>Tan, C N</creatorcontrib><creatorcontrib>Chew, J</creatorcontrib><creatorcontrib>Lim, J P</creatorcontrib><creatorcontrib>Ismail, N H</creatorcontrib><creatorcontrib>Ding, Y Y</creatorcontrib><creatorcontrib>Lim, W S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Frailty & Aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piodena-Aportadera, M R B</au><au>Lau, S</au><au>Tan, C N</au><au>Chew, J</au><au>Lim, J P</au><au>Ismail, N H</au><au>Ding, Y Y</au><au>Lim, W S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements</atitle><jtitle>Journal of Frailty & Aging</jtitle><addtitle>J Frailty Aging</addtitle><date>2024</date><risdate>2024</risdate><volume>13</volume><issue>2</issue><spage>98</spage><epage>107</epage><pages>98-107</pages><issn>2260-1341</issn><issn>2273-4309</issn><eissn>2273-4309</eissn><abstract>Screening tools such as calf circumference (CC) and Yubi-wakka (finger-ring) test have been recognized as effective tools by Asian Working Group for Sarcopenia 2019 (AWGS'19) for sarcopenia screening but their comparative agreement, diagnostic performance and validity are unclear.
This study aims to determine: (i)agreement between calf and finger-ring circumference, (ii)diagnostic performance for low muscle mass and AWGS'19 sarcopenia diagnosis, (iii)correlation with muscle mass, strength, and physical performance, and (iv)association with frailty, life space mobility and physical activity.
We studied 187 healthy community-dwelling older adults (mean age=66.8+7.0years) from the GERILABS-2 study. CC was measured via (i) both calves in sitting and standing positions, and (ii) Yubi-wakka test by encircling the thickest part of the non-dominant calf with index fingers and thumbs of both hands. We performed Cohen's kappa to check for agreement, area under receiver operating characteristic curve (AUC) to compare diagnostic performance, partial correlations adjusted for age and gender to compare convergent validity, and logistic regression to determine predictive validity for outcome measures.
Sarcopenia prevalence was 24.0% (AWGS'19). Yubi-wakka identified 16.6% of participants as screen-positive ("smaller"), showing moderate agreement only with non-dominant sitting CC measurements (k=0.421,p<0.001) and having lower diagnostic performance in determining low muscle mass (AUC=0.591 vs 0.855-0.870,p<0.001; sensitivity=57.1% vs 75.5-90.8%; specificity=58.4% vs 70.8-80.9%) and sarcopenia diagnosis (AUC=0.581 vs 0.788-0.818,p<0.001; sensitivity=55.6% vs 57.5-71.8%; specificity=74.4% vs 75.6-88.9%) compared to CC measurements. Yubi-wakka correlated significantly with muscle mass, grip strength and knee extension but not physical performance. When adjusted for age, gender and hypertension, Yubi-wakka was significantly associated with frailty (OR=3.96,95%CI:1.09-14.38), life space mobility (OR=2.38,95%CI:1.08-5.24) and physical activity (OR=2.50,95%CI:1.07-5.86).
Yubi-wakka provides a self-administered, low-cost and practicable community screening tool for sarcopenia. Our study affirmed the convergent and predictive validity of Yubi-wakka, albeit with lower sensitivity and specificity in diagnostic performance compared to CC measurements.</abstract><cop>France</cop><pub>Springer Nature B.V</pub><pmid>38616365</pmid><doi>10.14283/jfa.2024.25</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2260-1341 |
| ispartof | Journal of Frailty & Aging, 2024, Vol.13 (2), p.98-107 |
| issn | 2260-1341 2273-4309 2273-4309 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3039234979 |
| source | MEDLINE; ProQuest Central (Alumni Edition); Applied Social Sciences Index & Abstracts (ASSIA); Springer Nature - Complete Springer Journals; ProQuest Central Korea; ProQuest Central UK/Ireland; ProQuest Central |
| subjects | Aged Agreements Atrophy Body mass index Clinical medicine Community Convergent validity Cross-sectional studies Exercise Fingers Frailty Gender Grip strength Hand Strength Health care Hemoglobin Humans Hypertension Knee Joint Liver cancer Medical diagnosis Medical screening Metabolic syndrome Middle age Mobility Mortality Musculoskeletal system Older people Physical activity Predictive validity Primary care Risk factors Sarcopenia Sarcopenia - diagnosis Sarcopenia - epidemiology Tests Thumbs Validity Working groups |
| title | Yubi-Wakka Test for Sarcopenia Screening in the Community: Comparative Agreement, Diagnostic Performance and Validity with Calf Circumference Measurements |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A38%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Yubi-Wakka%20Test%20for%20Sarcopenia%20Screening%20in%20the%20Community:%20Comparative%20Agreement,%20Diagnostic%20Performance%20and%20Validity%20with%20Calf%20Circumference%20Measurements&rft.jtitle=Journal%20of%20Frailty%20&%20Aging&rft.au=Piodena-Aportadera,%20M%20R%20B&rft.date=2024&rft.volume=13&rft.issue=2&rft.spage=98&rft.epage=107&rft.pages=98-107&rft.issn=2260-1341&rft.eissn=2273-4309&rft_id=info:doi/10.14283/jfa.2024.25&rft_dat=%3Cproquest_cross%3E3037706994%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3037706994&rft_id=info:pmid/38616365&rfr_iscdi=true |